← Back to Search

Cannabinoid

CBD-WR for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Michael J Telch, Ph.D.
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to two-week follow-up
Awards & highlights

Study Summary

This trial studies if CBD oil can help people who experienced trauma by reducing symptoms and improving how they store memories.

Eligible Conditions
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to two-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to two-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Momentary Assessment of Distress Scale
Secondary outcome measures
Connor-Davidson Resilience Scale
Posttraumatic Cognition Inventory
Posttraumatic Growth Inventory
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: CBD-WRExperimental Treatment2 Interventions
300 mg CBD broad-spectrum oil will be administered within the reconsolidation window. Preclinical studies demonstrate that the disruptive effects of CBD oil on memory reconsolidation depend on the timing of pharmacological administration (within 6 hours of memory reactivation). Thus, participants will be asked to take a single 300mg oral dose of CBD broad-spectrum oil immediately after the trauma memory reactivation procedure.
Group II: CBD-ORActive Control2 Interventions
300mg CBD broad-spectrum oil will be administered outside of the reconsolidation window. Participants will be asked to take a single 300mg oral dose of CBD broad-spectrum oil approximately 24 hrs after the trauma memory reactivation procedure. Thus, CBD will be administered well beyond the critical period for memory reconsolidation. The inclusion of this third arm provides a more robust test of the specific reconsolidation theory-based study hypotheses and aids in controlling for any nonspecific possible anxiolytic effects of CBD.
Group III: PBO-WRPlacebo Group2 Interventions
Placebo oil will be administered within the reconsolidation window. Participants will be asked to take a single dose of an MCT coconut oil placebo solution immediately after the trauma memory reactivation procedure.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
350 Previous Clinical Trials
80,984 Total Patients Enrolled
Michael J Telch, Ph.D.Principal InvestigatorUniversity of Texas at Austin
4 Previous Clinical Trials
451 Total Patients Enrolled

Media Library

Cannabidiol (CBD) Broad-Spectrum Oil (Cannabinoid) Clinical Trial Eligibility Overview. Trial Name: NCT05892276 — N/A
Post-Traumatic Stress Disorder Research Study Groups: CBD-OR, CBD-WR, PBO-WR
Post-Traumatic Stress Disorder Clinical Trial 2023: Cannabidiol (CBD) Broad-Spectrum Oil Highlights & Side Effects. Trial Name: NCT05892276 — N/A
Cannabidiol (CBD) Broad-Spectrum Oil (Cannabinoid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05892276 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this experiment still open?

"This medical study is in search of roughly 120 individuals who suffer from post-traumatic stress disorder and are within the age range of 18 to 65."

Answered by AI

Is enrollment ongoing for this clinical investigation?

"Discerning from the data hosted on clinicaltrials.gov, this particular research is not presently enrolling participants. After being posted July 1st 2023 and revised May 26th 2023, there are 399 other studies currently recruiting individuals for participation."

Answered by AI

Does the eligibility for this medical experiment extend to younger people below 35 years of age?

"The scope of this clinical trial includes patients aged 18 and over, but below 65."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms
Michael J. Telch 2024. "Effects of CBD Oil on Memory Reconsolidation and Trauma-Related Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05892276.
~0 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top